Open AccessGiardiasis treatment: an update with a focus on refractory disease
Author(s) -
Kristine Mørch,
Kurt Hanevik
Publication year - 2020
Publication title -
current opinion in infectious diseases/current opinion in infectious diseases, with evaluated medline
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.68
H-Index - 103
eISSN - 1080-7861
pISSN - 0951-7375
DOI - 10.1097/qco.0000000000000668
Subject(s) - medicine , nitroimidazole , refractory (planetary science) , metronidazole , drug resistance , nitazoxanide , pharmacotherapy , giardia , disease , clinical trial , drug , paromomycin , intensive care medicine , pharmacology , antibiotics , pathology , veterinary medicine , microbiology and biotechnology , biology , astrobiology , aminoglycoside
Giardiasis remains a common cause of diarrhea and intestinal enteropathy globally. Here we give an overview of clinical treatment studies and discuss potential mechanisms and molecular targets for in-vitro testing of drug resistance.